Lina Quan

703 total citations
27 papers, 558 citations indexed

About

Lina Quan is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Lina Quan has authored 27 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Lina Quan's work include Immune Cell Function and Interaction (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Cancer-related molecular mechanisms research (4 papers). Lina Quan is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Cancer-related molecular mechanisms research (4 papers). Lina Quan collaborates with scholars based in China and United States. Lina Quan's co-authors include Aichun Liu, Xiuwen Lan, Yuanyuan Meng, Hongyu Gao, Xue Chen, Yingwei Xue, Yuyang Tian, Shujie Yan, Chunyan Yang and Sen Li and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Molecules.

In The Last Decade

Lina Quan

26 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lina Quan China 14 251 216 171 102 101 27 558
Jinbo Yang China 8 329 1.3× 417 1.9× 234 1.4× 169 1.7× 98 1.0× 13 734
Daniela Baus Germany 6 367 1.5× 361 1.7× 182 1.1× 128 1.3× 125 1.2× 8 682
Florian Corvinus Germany 7 264 1.1× 397 1.8× 213 1.2× 133 1.3× 101 1.0× 13 684
Anita L. Korapati United States 5 418 1.7× 258 1.2× 128 0.7× 79 0.8× 69 0.7× 6 638
David Paladino United States 6 270 1.1× 357 1.7× 81 0.5× 81 0.8× 124 1.2× 8 549
Elizabeth Foust United States 5 295 1.2× 367 1.7× 106 0.6× 66 0.6× 138 1.4× 5 593
Nashwa Kabil United States 12 307 1.2× 147 0.7× 88 0.5× 155 1.5× 53 0.5× 19 540
Lieqi Liu Canada 9 546 2.2× 207 1.0× 88 0.5× 89 0.9× 61 0.6× 9 770
Kaori Endo‐Umeda Japan 14 231 0.9× 113 0.5× 165 1.0× 68 0.7× 48 0.5× 24 591

Countries citing papers authored by Lina Quan

Since Specialization
Citations

This map shows the geographic impact of Lina Quan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lina Quan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lina Quan more than expected).

Fields of papers citing papers by Lina Quan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lina Quan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lina Quan. The network helps show where Lina Quan may publish in the future.

Co-authorship network of co-authors of Lina Quan

This figure shows the co-authorship network connecting the top 25 collaborators of Lina Quan. A scholar is included among the top collaborators of Lina Quan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lina Quan. Lina Quan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quan, Lina, et al.. (2025). Liquid‒liquid phase separation: a potentially fundamental mechanism of sepsis. Cell Death Discovery. 11(1). 310–310.
2.
Quan, Lina, et al.. (2024). Molecular hybridization method for obtaining paeonol-based fibrate derivatives with potent lipid-lowering and hepatoprotective activity. Medicinal Chemistry Research. 33(5). 796–810. 1 indexed citations
3.
Wang, Xinya, et al.. (2024). Prognostic marker CD27 and its micro-environmental in multiple myeloma. BMC Cancer. 24(1). 352–352. 2 indexed citations
4.
5.
Chen, Yao, et al.. (2022). HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma. Journal of Translational Medicine. 20(1). 537–537. 17 indexed citations
6.
Wang, Xiaoping, Xiaoping Wang, Pengfei Wang, et al.. (2019). Investigating the effects and possible mechanisms of danshen- honghua herb pair on acute myocardial ischemia induced by isoproterenol in rats. Biomedicine & Pharmacotherapy. 118. 109268–109268. 35 indexed citations
7.
Tian, Yuyang, et al.. (2018). miR-26b-5p suppresses proliferation and promotes apoptosis in multiple myeloma cells by targeting JAG1. Pathology - Research and Practice. 214(9). 1388–1394. 41 indexed citations
8.
Kong, Dejuan, et al.. (2018). Enhanced antitumor effect of combination of annexin A1 knockdown and bortezomib treatment in multiple myeloma in vitro and in vivo. Biochemical and Biophysical Research Communications. 505(3). 720–725. 12 indexed citations
9.
Li, Jiang, Jinghui Zhang, Aichun Liu, et al.. (2018). Lentivirus-mediated down-regulation of CK2α inhibits proliferation and induces apoptosis of malignant lymphoma and leukemia cells. Biochemistry and Cell Biology. 96(6). 786–796. 2 indexed citations
10.
Quan, Lina, et al.. (2018). Three novel microRNAs based on microRNA signatures for gastric mucosa- associated lymphoid tissue lymphoma. Neoplasma. 65(3). 339–348. 4 indexed citations
11.
Quan, Lina, Xiuwen Lan, Yuanyuan Meng, et al.. (2018). BTLA marks a less cytotoxic T-cell subset in diffuse large B-cell lymphoma with high expression of checkpoints. Experimental Hematology. 60. 47–56.e1. 33 indexed citations
12.
Meng, Yuanyuan, Lina Quan, & Aichun Liu. (2017). Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions. Gene. 642. 205–211. 37 indexed citations
13.
14.
Lan, Xiuwen, Sen Li, Hongyu Gao, et al.. (2017). Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis. OncoTargets and Therapy. Volume 10. 919–926. 77 indexed citations
15.
Liu, Juan, et al.. (2017). Over-activated PD-1/PD-L1 axis facilitates the chemoresistance of diffuse large B-cell lymphoma cells to the CHOP regimen. Oncology Letters. 15(3). 3321–3328. 16 indexed citations
16.
Quan, Lina, et al.. (2016). Abnormal vascular endothelial growth factor protein expression may be correlated with poor prognosis in diffuse large B-cell lymphoma: A meta-analysis. Journal of Cancer Research and Therapeutics. 12(2). 605–611. 5 indexed citations
17.
Lan, Xiuwen, Jun Xing, Hongyu Gao, et al.. (2016). Decreased Expression of Selenoproteins as a Poor Prognosticator of Gastric Cancer in Humans. Biological Trace Element Research. 178(1). 22–28. 30 indexed citations
18.
Quan, Lina, Xue Chen, Aichun Liu, et al.. (2015). PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro. PLoS ONE. 10(9). e0136476–e0136476. 60 indexed citations
19.
Quan, Lina, et al.. (2011). [Effects of As2O3 and all-trans retinoic acid on the growth of HeLa cell line and their relation with gene NDRG1].. PubMed. 33(1). 8–12. 3 indexed citations
20.
Deng, Xian‐Qing, Lina Quan, Mingxia Song, Cheng‐Xi Wei, & Zhe‐Shan Quan. (2011). Synthesis and anticonvulsant activity of 7-phenyl-6,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-ones and their derivatives. European Journal of Medicinal Chemistry. 46(7). 2955–2963. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinbo Yang Breakdown of academic impact, for papers by Daniela Baus Breakdown of academic impact, for papers by Florian Corvinus Breakdown of academic impact, for papers by Anita L. Korapati Breakdown of academic impact, for papers by David Paladino Breakdown of academic impact, for papers by Elizabeth Foust Breakdown of academic impact, for papers by Nashwa Kabil Breakdown of academic impact, for papers by Lieqi Liu Breakdown of academic impact, for papers by Kaori Endo‐Umeda
Rankless by CCL
2026